Metabolic syndrome in adult cancer survivors: A meta-analysis

Diabetes Research and Clinical Practice

Volumn 95, Issue 2, 2012, Pages 275-282

  Jung, Hyun Suk ^a   Myung, Seung Kwon ^b   Kim, Byung Su ^c   Seo, Hong Gwan ^b,d  

^a Sungkyunkwan University   (South Korea)

^b National Cancer Center   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

^d National Cancer Control Institute National   (South Korea)

Author keywords

Cancer survivor; Meta analysis; Metabolic syndrome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER SURVIVOR; CHRONIC MYELOID LEUKEMIA; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; EMBASE; HEMATOLOGIC MALIGNANCY; HUMAN; MEDLINE; METABOLIC SYNDROME X; NONHODGKIN LYMPHOMA; OVARY CANCER; PROSTATE CANCER; RISK ASSESSMENT; SARCOMA; SYSTEMATIC REVIEW; TESTIS CANCER;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; METABOLIC SYNDROME X; RISK FACTORS; SURVIVORS; UNITED STATES;

EID: 84856351186     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.08.029     Document Type: Article

References (41)

1. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007, 8:784-796.
2. Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582.
3. Huddart R.A., Norman A., Shahidi M., Horwich A., Coward D., Nicholls J., et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003, 21:1513-1523.
4. Talvensaari K.K., Lanning M., Tapanainen P., Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996, 81:3051-3055.
5. Meinardi M.T., Gietema J.A., van der Graaf W.T., van Veldhuisen D.J., Runne M.A., Sluiter W.J., et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000, 18:1725-1732.
6. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403-414.
7. Reaven G.M. The metabolic syndrome: time to get off the merry-go-round?. J Intern Med 2011, 269:127-136.
8. Nuver J., Smit A.J., Wolffenbuttel B.H., Sluiter W.J., Hoekstra H.J., Sleijfer D.T., et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005, 23:3718-3725.
9. Braga-Basaria M., Dobs A.S., Muller D.C., Carducci M.A., John M., Egan J., et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 2006, 24:3979-3983.
10. Follin C., Thilen U., Ahren B., Erfurth E.M. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 2006, 91:1872-1875.
11. Gurney J.G., Ness K.K., Sibley S.D., O'Leary M., Dengel D.R., Lee J.M., et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006, 107:1303-1312.
12. Haugnes H.S., Aass N., Fosså S.D., Dahl O., Klepp O., Wist E.A., et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 2007, 18:241-248.
13. Annaloro C., Usardi P., Airaghi L., Giunta V., Forti S., Orsatti A., et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:797-804.
14. Hoffman K.E., Derdak J., Bernstein D., Reynolds J.C., Avila N.A., Gerber L., et al. Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 2008, 50:341-346.
15. Liavaag A.H., Tonstad S., Pripp A.H., Tropé C., Dørum A. Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study. Int J Gynecol Cancer 2009, 19:634-640.
16. Majhail N.S., Flowers M.E., Ness K.K., Jagasia M., Carpenter P.A., Arora M., et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009, 43:49-54.
17. Nuver J., Smit A.J., Postma A., Sleijfer D.T., Gietema J.A. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002, 28:195-214.
18. de Haas E.C, Oosting S.F., Lefrandt J.D., Wolffenbuttel B.H., Sleijfer D.T., Gietema J.A. The metabolic syndrome in cancer survivors. Lancet Oncol 2010, 11:193-203.
19. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
21. Follin C., Thilén U., Ahrén B., Erfurth E.M. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 2006, 91:1872-1875.
22. Pietilä S., Mäkipernaa A., Sievänen H., Koivisto A.M., Wigren T., Lenko H.L. Obesity and metabolic changes are common in young childhood brain tumor survivors. Pediatr Blood Cancer 2009, 52:853-859.
23. Oeffinger K.C., Mertens A.C., Sklar C.A., Yasui Y., Fears T., Stovall M., et al. Childhood Cancer Survivor Study. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003, 21:1359-1365.
24. Gurney J.G., Ness K.K., Stovall M., Wolden S., Punyko J.A., Neglia J.P., et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab 2003, 88:4731-4739.
25. Janiszewski P.M., Oeffinger K.C., Church T.S., Dunn A.L., Eshelman D.A., Victor R.G., et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 2007, 92:3816-3821.
26. Warner J.T, Bell W., Webb D.K.H., Gregory J.W. Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy. Arch Dis Child 1997, 76:298-303.
27. Mayer E.I.E., Reuter M., Dopfer R.E., Ranke M.B. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 2000, 53:193-199.
28. Brennan B.M, Rahim A., Blum W.F., Adams J.A., Eden O.B., Shalet S.M. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?. Clin Endocrinol 1999, 50:163-169.
29. He K., Liu K., Daviglus M.L., Morris S.J., Loria C.M., Van Horn L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113:1675-1682.
30. Lajer H., Bundgaard H., Secher N.H., Hansen H.H., Kjeldsen K., Daugaard G. Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. Br J Cancer 2003, 89:1633-1637.
31. Nuver J., Smit A.J., van der Meer J., van den Berg M.P., van der Graaf W.T., Meinardi M.T., et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 2005, 23:9130-9137.
32. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
33. Ness K.K., Hudson M.M., Ginsberg J.P., Nagarajan R., Kaste S.C., Marina N., et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009, 27:2382-2389.
34. Herman D.R., Ganz P.A., Petersen L., Greendale G.A. Obesity and cardiovascular risk factors in younger breast cancer survivors: the Cancer and Menopause Study (CAMS). Breast Cancer Res Treat 2005, 93:13-23.
35. Baker K.S., Ness K.K., Steinberger J., Carter A., Francisco L., Burns L.J., et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 2007, 109:1765-1772.
36. Tichelli A., Bhatia S., Socie G. Cardiac cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008, 142:11-26.
37. Tichelli A., Bucher C., Rovó A., Stussi G., Stern M., Paulussen M., et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007, 110:3463-3471.
38. Kauppila M., Koskinen P., Irjala K., Remes K., Viikari J. Long-term effects of allogeneic bone marrow transplantation BMT on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplant 1998, 22:331-337.
39. Rennie K.L, McCarthy N., Yazdgerdi S., Marmot M., Brunner E. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 2003, 32:600-606.
40. Meacham L.R., Gurney J.G., Mertens A.C., Ness K.K., Sklar C.A., Robison L.L., et al. Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer 2005, 103:1730-1739.
41. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.